Order Article Reprints

Alqahtani SA, Alshehri HH, Ashour H, Abdallah H, Rashed L, Badi RM, Mohammed MED, Al-Ani B, Alzamil NM, Albawardi A, et al. Quercetin Attenuates Non-Alcoholic Fatty Liver Disease in Association with the Inhibition of Hepatic IL-1β/iNOS and IL-1β/CD45 Axes of Inflammation and Fibrosis Accompanied by Reduced Endogenous Metabolites and Apoptosis. Metabolites. 2026; 16(4):284. https://doi.org/10.3390/metabo16040284

Alqahtani, Saif A., Hanan H. Alshehri, Hend Ashour, Hend Abdallah, Laila Rashed, Rehab M. Badi, Muataz E. D. Mohammed, Bahjat Al-Ani, Norah M. Alzamil, Alia Albawardi, and et al. 2026. "Quercetin Attenuates Non-Alcoholic Fatty Liver Disease in Association with the Inhibition of Hepatic IL-1β/iNOS and IL-1β/CD45 Axes of Inflammation and Fibrosis Accompanied by Reduced Endogenous Metabolites and Apoptosis" Metabolites 16, no. 4: 284. https://doi.org/10.3390/metabo16040284

Alqahtani, S. A., Alshehri, H. H., Ashour, H., Abdallah, H., Rashed, L., Badi, R. M., Mohammed, M. E. D., Al-Ani, B., Alzamil, N. M., Albawardi, A., & Aboulhoda, B. E. (2026). Quercetin Attenuates Non-Alcoholic Fatty Liver Disease in Association with the Inhibition of Hepatic IL-1β/iNOS and IL-1β/CD45 Axes of Inflammation and Fibrosis Accompanied by Reduced Endogenous Metabolites and Apoptosis. Metabolites, 16(4), 284. https://doi.org/10.3390/metabo16040284